Background Cholangiocarcinoma management is constantly being updated in view of
existing evidence in order to establish practice guidelines and consensus statements …

Background The Cholangiocarcinoma treatment options are constantly being updated in
view of existing evidence in order to establish practice guidelines and consensus …

Background The cholangiocarcinoma management is continually reviewed in the current
evidence basis in order to develop practice guidelines and consensus statements. However …

Background: The management of cholangiocarcinoma is continually reviewed on a current
evidence basis to develop practice guidelines and consensus statements. However, the …

Background At present, intrahepatic cholangiocarcinoma is a contraindication for liver
transplantation. However, previous studies in this field did not preselect patients on the basis …

Background Liver transplantation (LT) is considered a therapeutic option for unresectable
perihilar cholangiocarcinoma (PHC) within defined criteria. It remains uncertain whether …

The aim of our study was to evaluate the efficacy and safety of liver transplantation in
patients with cholangiocarcinoma. According to the requirements of Cochrane systematic …

Cholangiocarcinoma should theoretically be a disease amenable to orthotopic liver
transplantation (OLT). Its metastatic potential is often limited, so it typically remains confined …

Liver transplantation (LT) for cholangiocarcinoma (CCA) remains limited to a small number
of centers. Although the role of neoadjuvant therapy (NAT) has been explored over time, an …

The very early experience with liver transplantation (LT) for cholangiocarcinoma (CC) was
dismal because of the poor survival outcomes and the high recurrence rates. However, LT …